Literature DB >> 15377057

Cell membrane fatty acid composition differs between normal and malignant cell lines.

Xialong Meng1, Neil H Riordan, Hugh D Riordan, Nina Mikirova, James Jackson, Michael J González, Jorge R Miranda-Massari, Edna Mora, Waleska Trinidad Castillo.   

Abstract

Twenty-eight fatty acids (C8:0 to C24:l n-9) were measured by gas chromatography in four normal cell lines (C3H / 10T1 / 2, CCD-18Co, CCD-25SK and CCD-37Lu) and seven cancer cell lines (C-41, Caov-3, LS-180, PC-3, SK-MEL-28, SK-MES-1 and U-87 MG). Results show differences in the content and proportions of fatty acids when comparing cancer cell lines with their normal counterparts. Cancer cell lines showed lower C20: 4 n-6, C24:1 n-9, polyunsaturated fatty acids (PUFA's) and ratios of C20:4 n-6 to C20:5 n-3 and C16:0 to C18:1 n-9 and stearic to oleic (SA/OA) than their normal counterparts. All cancer cell lines had SA/OA ratios lower than 7.0 while normal cell lines had ratios greater than 0.7 (p<0.05). In addition, the ratios of total saturated fatty acids (SFA) to PUFA'S and the concentration of C18:1 n-9, C18:2 n-6, C20:5 n-3 were higher in cancer cell lines as compared to normal cell lines. A positive correlation was detected between C16:0 and longer SFA'S (r = +0.511, p<0.05) in normal cell lines whereas a negative correlation (r=0.608, p<0.05) was obtained for malignant cell lines. Moreover, cancerous cell lines exhibited a particular desaturation defect and an abnormal incorporation of C18:2 n-6 and C20-4 n-6 fatty acids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15377057

Source DB:  PubMed          Journal:  P R Health Sci J        ISSN: 0738-0658            Impact factor:   0.705


  6 in total

1.  Ectopically expressed human tumor biomarker MutS homologue 2 is a novel endogenous ligand that is recognized by human γδ T cells to induce innate anti-tumor/virus immunity.

Authors:  Yumei Dai; Hui Chen; Chen Mo; Lianxian Cui; Wei He
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

Review 2.  Cell membrane modulation as adjuvant in cancer therapy.

Authors:  Sara Zalba; Timo L M Ten Hagen
Journal:  Cancer Treat Rev       Date:  2016-11-09       Impact factor: 12.111

3.  Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells.

Authors:  Hanan Abumanhal-Masarweh; Dana da Silva; Maria Poley; Assaf Zinger; Evgenya Goldman; Nitzan Krinsky; Ron Kleiner; Gal Shenbach; Josh E Schroeder; Jeny Shklover; Janna Shainsky-Roitman; Avi Schroeder
Journal:  J Control Release       Date:  2019-06-22       Impact factor: 9.776

4.  Tri-2-Hydroxyarachidonein Induces Cytocidal Autophagy in Pancreatic Ductal Adenocarcinoma Cancer Cell Models.

Authors:  Javier Fernández-Díaz; Roberto Beteta-Göbel; Manuel Torres; Joan Cabot; Paula Fernández-García; Victoria Lladó; Pablo V Escribá; Xavier Busquets
Journal:  Front Physiol       Date:  2022-01-20       Impact factor: 4.566

5.  Metabolic Profiling Comparison of Human Pancreatic Ductal Epithelial Cells and Three Pancreatic Cancer Cell Lines using NMR Based Metabonomics.

Authors:  Miki Watanabe; Sulaiman Sheriff; Kenneth B Lewis; Junho Cho; Stuart L Tinch; Ambikaipakan Balasubramaniam; Michael A Kennedy
Journal:  J Mol Biomark Diagn       Date:  2012-03-12

6.  Calcium electroporation for treatment of sarcoma in preclinical studies.

Authors:  Stine Krog Frandsen; Julita Kulbacka; Anna Szewczyk; Julie Gehl; Malgorzata Daczewska; Jolanta Saczko
Journal:  Oncotarget       Date:  2018-01-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.